Cobus Loots, CEO of Pan African Resources, on delivering sector-leading returns for shareholders. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIofina Regulatory News (IOF)

Share Price Information for Iofina (IOF)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 21.50
Bid: 20.50
Ask: 22.50
Change: -0.15 (-0.71%)
Spread: 2.00 (9.756%)
Open: 21.25
High: 21.10
Low: 21.00
Prev. Close: 21.25
IOF Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

IO#4 and IO#5 Update

28 Feb 2014 07:01

RNS Number : 1577B
Iofina PLC
28 February 2014
 

 

 

28 February 2014

 

Iofina plc.

("Iofina" or the "Group")

(LSE AIM: IOF)

 

Completion of IO#4 Iodine Extraction Plant

IO#5 on track for completion in March

 

Iofina, specialists in the exploration and production of iodine and iodine specialty chemical derivatives, is pleased to announce that the construction of the Group's IO#4 iodine extraction plant based on Iofina's WET® IOSorb™ technology is complete and under the control of Iofina's operation team. The tie-in to the well operator is also complete and has been approved by the operator. The plant is located in the vicinity of IO#2 and IO#3.

 

The Board is pleased to announce that the Group's experienced startup and production staff have taken charge of the facility from construction and fabrication teams on site and are in the process of hydro testing the plant prior to the acceptance of brine water, as well as testing of in-line automation systems. The Group hoped to begin hydro testing at IO#4 earlier in February but was limited by winter storms and cold weather. Operator tie-in was also scheduled to be complete at that time but was delayed due to cold weather in the area.

 

Completion of construction of IO#5 is expected in March and the plant will be turned over to operations staff at that time. Production of iodine for both IO#4 and IO#5 is conditional upon final regulatory inspection and approval. Inspection is expected to occur in mid-March with approval thereafter.

 

Construction of IO#6 continues with completion expected in the 2nd quarter of 2014.

 

Iofina's business strategy is to identify, develop, build, own and operate iodine extraction plants currently focused in North America based on Iofina's WET® and IOsorb™ technology. Today's news follows on from the successful commissioning of the Group's IO#1, IO#2, and IO#3 iodine extraction plants.

 

Commenting on today's news, Iofina's Chief Executive George Lantz commented:"The completion of IO#4 solidifies Iofina's capabilities of constructing and operating multiple plants simultaneously. Production from IO#1-IO#3, shortly to be complemented by IO#4, together with anticipated production from IO5# and IO6#, further advances Iofina as a major player in the iodine market."

 

For further information, please contact:

 

George Lantz, CEO

Iofina plc

Tel: +44 (0) 20 3006 3135

www.iofina.com

 

John Prior/Rupert Krefting/Huw Jeremy

Numis

Tel: +44(0)20 7260 1000

 

Rob Collins

GMP Securities

Tel: +44(0)20 7647 2800

 

Media Contact:

Dominic Barretto/Anna Legge

Yellow Jersey PR Limited

Tel: +44(0) 7768 537 739

 

About Iofina

 

Iofina specializes in the exploration and production of iodine, iodine specialty chemical derivatives, and produced water. Iofina's business strategy is to identify, develop, build, own and operate iodine extraction plants currently focused in North America based on Iofina's WET® IOsorb™ technology. Iofina has iodine production operations in the United States, specifically in Texas, Montana, and Oklahoma. The Group has complete vertical integration from the production of iodine in the field to the manufacture of the chemical end products derived from iodine to the consumer and the recycling of iodine using iodinated side-streams from waste chemical processes in Europe, North America and Asia. The Group utilizes its portfolio of patented and patent pending technology, proprietary methods and trademarks throughout all business lines.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCTRMLTMBITBAI
Date   Source Headline
14th Apr 20107:00 amRNSThird Party Iodine Agreement Signed
22nd Mar 20108:36 amRNSFirst Third Party Iodine Extraction and Collection
22nd Mar 20107:00 amRNSRe Iodine Extraction and Collection Agreement
8th Mar 20107:02 amRNSOperations Update
8th Mar 20107:00 amRNSManagement changes
12th Jan 20103:09 pmRNSDirectorate Change
8th Jan 20107:00 amRNSDirector's Dealings
11th Dec 20096:00 pmRNSHolding in Company
22nd Oct 20095:14 pmRNSChange of Name of Nominated Adviser
19th Oct 20094:07 pmRNSExercise of Options
30th Sep 20097:00 amRNSHalf Yearly Report
10th Aug 200911:13 amRNSManagement Appointments
27th Jul 20097:00 amRNSAcquisition and Operations Update
23rd Jun 200910:20 amRNSResult of AGM
22nd Jun 20094:40 pmRNSSecond Price Monitoring Extn
22nd Jun 20094:35 pmRNSPrice Monitoring Extension
27th May 20094:19 pmRNSPosting of Annual Report
12th May 20097:00 amRNSFinal Results
25th Feb 20099:57 amRNSHolding(s) in Company
23rd Feb 20091:55 pmRNSHolding(s) in Company
19th Feb 200911:06 amRNSDirector/PDMR Shareholding
12th Feb 20094:44 pmRNSPlacing
13th Jan 20097:00 amRNSDirectorate Change
13th Jan 20097:00 amRNSDrilling Update
19th Dec 20085:00 pmRNSDirector/PDMR Shareholding
17th Dec 20087:00 amRNSOperational Update
7th Nov 20089:59 amRNSHolding(s) in Company
31st Oct 200810:53 amRNSDirector/PDMR Shareholding
30th Oct 20083:39 pmRNSHolding(s) in Company
16th Sep 20085:26 pmRNSDirector/PDMR Shareholding
16th Sep 20084:28 pmRNSDirector/PDMR Shareholding
12th Sep 20085:03 pmRNSDirectorate Change
9th Sep 20087:00 amRNSAppointment of Non Executive
9th Sep 20087:00 amRNSInterim Results
13th Aug 20087:00 amRNSAcquisition
25th Jul 20085:10 pmRNSHolding(s) in Company
16th Jul 20087:00 amRNSOperations Update
10th Jun 20081:29 pmBUSRule 8.3 - INFORMA PLC
9th May 20087:00 amRNSPlacing and Admission to AIM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.